277 related articles for article (PubMed ID: 25954477)
1. Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.
Jiménez-Romero C; Justo-Alonso I; Cambra-Molero F; Calvo-Pulido J; García-Sesma Á; Abradelo-Usera M; Caso-Maestro O; Manrique-Municio A
World J Hepatol; 2015 May; 7(7):942-53. PubMed ID: 25954477
[TBL] [Abstract][Full Text] [Related]
2. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases.
Jiménez-Romero C; Manrique Municio A; Marqués Medina E; Colina F; Ortega Domene P; Gómez Sanz R; Meneu Diaz JC; Abradelo de Usera M; Moreno Elola A; Moreno Gonzalez E
Transplant Proc; 2006 Oct; 38(8):2505-7. PubMed ID: 17097982
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.
Chak E; Saab S
Liver Int; 2010 Oct; 30(9):1247-58. PubMed ID: 20602682
[TBL] [Abstract][Full Text] [Related]
4.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
5. Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center.
Nure E; Frongillo F; Lirosi MC; Grossi U; Sganga G; Avolio AW; Siciliano M; Addolorato G; Mariano G; Agnes S
Transplant Proc; 2013 Sep; 45(7):2733-5. PubMed ID: 24034035
[TBL] [Abstract][Full Text] [Related]
6. Upper aerodigestive tract and lung tumors after liver transplantation.
Jiménez C; Marqués E; Loinaz C; Romano DR; Gómez R; Meneu JC; Hernández-Vallejo G; Alonso O; Abradelo M; Garcia I; Moreno E
Transplant Proc; 2003 Aug; 35(5):1900-1. PubMed ID: 12962840
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of development of lung tumors after liver transplantation.
Jiménez C; Marqués E; Manrique A; Loinaz C; Gómez R; Meneu JC; Abradelo M; Pérez B; Moreno A; García I; Moreno E
Transplant Proc; 2005 Nov; 37(9):3970-2. PubMed ID: 16386600
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for the development of lung tumors after liver transplantation.
Jiménez C; Manrique A; Marqués E; Ortega P; Loinaz C; Gómez R; Meneu JC; Abradelo M; Moreno A; López A; Moreno E
Transpl Int; 2007 Jan; 20(1):57-63. PubMed ID: 17181654
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
10. Switching to sirolimus monotherapy for de novo tumors after liver transplantation. A preliminary experience.
Jiménez-Romero C; Manrique A; Marqués E; Calvo J; Sesma AG; Cambra F; Abradelo M; Sterup RM; Olivares S; Justo I; Colina F; Moreno E
Hepatogastroenterology; 2011; 58(105):115-21. PubMed ID: 21510297
[TBL] [Abstract][Full Text] [Related]
11. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
Yao FY; Gautam M; Palese C; Rebres R; Terrault N; Roberts JP; Peters MG
Clin Transplant; 2006; 20(5):617-23. PubMed ID: 16968488
[TBL] [Abstract][Full Text] [Related]
12. Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis.
Kenngott S; Gerbes AL; Schauer R; Bilzer M
Transpl Int; 2003 Sep; 16(9):639-41. PubMed ID: 12768231
[TBL] [Abstract][Full Text] [Related]
13. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
Kochhar G; Singh T; Dust H; Lopez R; McCullough AJ; Liu X; Fung J; Shen B
Inflamm Bowel Dis; 2016 Jul; 22(7):1670-8. PubMed ID: 27306073
[TBL] [Abstract][Full Text] [Related]
14. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
[TBL] [Abstract][Full Text] [Related]
15. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
16. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
17. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.
Kauffman HM; Cherikh WS; Cheng Y; Hanto DW; Kahan BD
Transplantation; 2005 Oct; 80(7):883-9. PubMed ID: 16249734
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for cancer after liver transplantation.
Vallejo GH; Romero CJ; de Vicente JC
Crit Rev Oncol Hematol; 2005 Oct; 56(1):87-99. PubMed ID: 15979889
[TBL] [Abstract][Full Text] [Related]
19. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.
Mukthinuthalapati PK; Gotur R; Ghabril M
World J Hepatol; 2016 Apr; 8(12):533-44. PubMed ID: 27134701
[TBL] [Abstract][Full Text] [Related]
20. De novo tumors are a major cause of late mortality after orthotopic liver transplantation.
Baccarani U; Adani GL; Serraino D; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; Piselli P; De Paoli A; Bresadola V; Risaliti A; Toniutto P; Cillo U; Bresadola F; Burra P
Transplant Proc; 2009 May; 41(4):1303-5. PubMed ID: 19460546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
